Z-1506-2021 Class III Ongoing

Recalled by Datascope Corp. — Mahwah, NJ

FDA device recall Z-1506-2021 was initiated by Datascope Corp. on Mar 22, 2021 and is designated Class III. Reason for recall: There are cybersecurity vulnerabilities in a widely used low-level TCP/IP software library that may result in a loss of communication to the Hospital Information System/Clinical Information System… The recall status is ongoing. Affected quantity: 10087 total.

Recall details

Product Type
Devices
Report Date
May 5, 2021
Initiation Date
Mar 22, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
10087 total

Product description

Cardiosave Hybrid IABP - Product Usage: used to inflate and deflate intra-aortic balloons. It provides temporary support to the left ventricle via the principle of counterpulsation, Model Numbers 0998-00-0800-32, 0998-00-0800-33, 0998-00-0800-34, 0998-00-0800-35, 0998-00-0800-45, 0998-00-0800-52, 0998-00-0800-53, 0998-00-0800-55, 0998-00-0800-65

Reason for recall

There are cybersecurity vulnerabilities in a widely used low-level TCP/IP software library that may result in a loss of communication to the Hospital Information System/Clinical Information System (HIS/CIS).

Distribution pattern

Worldwide distribution - US Nationwide distribution.

Code information

All Systems. UDI: 10607567111117 10607567109008 10607567111940 10607567109107 10607567108421 10607567108438 10607567108391 10607567108414 10607567113432

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1506-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1506-2021. Report a data issue: hello@regdatalab.com.